Xi Jia

Xi Jia

Auto-generated profile, based on publicly available information

Xi Jia

Chinese Academy of Medical Sciences and Peking Union Medical College

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2021 in Radiology
Verified
Journal Article
Closed access
HXhan Xiaoyu
han Xiaoyu
YFYanqing Fan
Yanqing Fan
OAOsamah Alwalid
Osamah Alwalid
XZXin Zhang
Xin Zhang
XJXi Jia
Xi Jia
HSHeshui Shi
Heshui Shi
Fibrotic interstitial lung abnormalities in survivors of severe COVID-19 depicted on 6-month CT scans were persistent on 1-year CT scans and were negatively correlated with the lung diffusion capacity.

1 April 2023 in Radiology
Verified
Journal Article
Closed access
HXhan Xiaoyu
han Xiaoyu
LCLu Chen
Lu Chen
YFYanqing Fan
Yanqing Fan
OAOsamah Alwalid
Osamah Alwalid
XJXi Jia
Xi Jia
HSHeshui Shi
Heshui Shi
Background Information on pulmonary sequelae and pulmonary function 2 years after recovery from SARS-CoV-2 infection is lacking. Purpose To longitudinally assess changes in chest CT abnormalities and pulmonary function in individuals after SARS-CoV-2 infection. Materials and Methods In this prospective study, participants discharged from the hospital after SARS-CoV-2 infection from January 20 to March 10, 2020, were considered for enrollment. Participants without chest CT scans at admission or with complete resolution of lung abnormalities at discharge were excluded. Serial chest CT scans and pulmonary function test results were obtained 6 months (June 20 to August 31, 2020), 12 months (December 20, 2020, to February 3, 2021), and 2 years (November 16, 2021, to January 10, 2022) after symptom onset. The term interstitial lung abnormality (ILA) and two subcategories, fibrotic ILAs and nonfibrotic ILAs, were used to describe residual CT abnormalities on follow-up CT scans. Differences between groups were compared with the χ2 test, Fisher exact test, or independent samples t test. Results Overall, 144 participants (median age, 60 years [range, 27-80 years]; 79 men) were included. On 2-year follow-up CT scans, 39% of participants (56 of 144) had ILAs, including 23% (33 of 144) with fibrotic ILAs and 16% (23 of 144) with nonfibrotic ILAs. The remaining 88 of 144 participants (61%) showed complete radiologic resolution. Over 2 years, the incidence of ILAs gradually decreased (54%, 42%, and 39% of participants at 6 months, 12 months, and 2 years, respectively; P < .001). Respiratory symptoms (34% vs 15%, P = .007) and abnormal diffusing capacity of lung for carbon monoxide (43% vs 20%, P = .004) occurred more frequently in participants with ILAs than in those with complete radiologic resolution. Conclusion More than one-third of participants had persistent interstitial lung abnormalities 2 years after COVID-19 infection, which were associated with respiratory symptoms and decreased diffusion pulmonary function. Chinese Clinical Trial Registry no. ChiCTR2000038609 © RSNA, 2023 Supplemental material is available for this article. See also the editorial by van Beek in this issue.

6 October 2026 in Journal of the American Heart Association
Verified
Journal Article
Open access
PZPengyu Zhou
Pengyu Zhou
KZKankan Zhao
Kankan Zhao
KAKaisaierjiang Aisikaier
Kaisaierjiang Aisikaier
ZDZhixiang Dong
Zhixiang Dong
XMXuan Ma
Xuan Ma
SZShihua Zhao
Shihua Zhao
Background: The prevalence, anatomic distribution, enhancement patterns, and prognostic value of nonischemic late gadolinium enhancement (NI‐LGE) in patients with prior myocardial infarction were not systematically investigated. Methods: A total of 948 patients (mean±SD age, 56.2±10.9 years; 88.4% men) diagnosed with prior myocardial infarction by cardiac magnetic resonance imaging were analyzed, excluding those with coexisting nonischemic cardiomyopathies or myocarditis. NI‐LGE was defined as midwall or subepicardial enhancement. Competing risk analysis was performed to mitigate the influence of competing events. Results: Among these, NI‐LGE was observed in 78 patients (8.2%), with septal involvement present in all cases. Lower left ventricular ejection fraction (odds ratio [OR]=0.97, P =0.01) and larger end‐diastolic volume index (OR=1.01, P <0.001) were independently associated with NI‐LGE. During a median follow‐up of 69.6 months (interquartile range, 49.7–80.9 months), 99 (10.4%) and 63 (6.6%) experienced heart failure (HF)– and sudden cardiac death–related events, respectively. NI‐LGE was associated with a markedly increased risk of HF‐related events (subdistribution hazard ratio [sHR]=5.98, P <0.001) after adjusting for the confounders, but not sudden cardiac death ( P =0.65). NI‐LGE improved the model discrimination and fit performance (C‐index: 0.84–0.87; likelihood ratio: 1168.0–1106.1, both P <0.001) for the HF‐related events beyond left ventricular ejection fraction and late gadolinium enhancement extent. Moreover, NI‐LGE involving both the septum and free wall conferred a higher risk of HF‐related events than isolated septal involvement (sHR=2.42, P =0.02). Conclusions: NI‐LGE occurs in 8.2% of patients with prior myocardial infarction, predominantly involving the interventricular septum. As a potential marker of adverse remodeling, NI‐LGE might provide incremental prognostic value for HF‐related outcomes beyond traditional markers.

12 November 2026 in Journal of the American Heart Association
Verified
Journal Article
Closed access
WXWenqing Xu
Wenqing Xu
XMXuan Ma
Xuan Ma
YSYanyan Song
Yanyan Song
ZDZhixiang Dong
Zhixiang Dong
SYShujuan Yang
Shujuan Yang
SZShihua Zhao
Shihua Zhao
Background: Advanced arrhythmogenic right ventricular cardiomyopathy is associated with a high risk of malignant ventricular arrhythmias (MVA) and end‐stage heart failure (HF). However, the prognostic role of right atrial (RA) mechanics, as quantified by cardiac magnetic resonance imaging (CMR), remains largely unexplored. Methods: Consecutive patients with arrhythmogenic right ventricular cardiomyopathy undergoing CMR between 2014 and 2021 were retrospectively included. Demographics, clinical history, and strain parameters were collected. The primary clinical end points were end‐stage HF and MVA. Results: A total of 316 patients (mean age 38±15 years; 66.1% men) were included. Over a median follow‐up of 5.3 years, 49 developed end‐stage HF and 103 experienced MVA outcomes. Multivariable Cox and Fine‐Gray models showed that impaired RA reservoir strain was an independent predictor of end‐stage HF (hazard ratio [HR] 0.92, 95% CI 0.89–0.96, P <0.001) and MVA outcomes (subdistribution hazard ratio (sHR) 0.98, 95% CI 0.96–0.99, P =0.025), with added prognostic value beyond clinical and imaging variables, improving the C‐statistic to 0.84 and 0.70, respectively. Kaplan–Meier survival curves indicated that RA reservoir strain <18.6% was associated with higher end‐stage HF risk, consistent across subgroups regardless of left ventricular involvement (both log‐rank P <0.05). The association between RA reservoir strain <23.0% and MVA was significant in the overall cohort ( P <0.001) and in patients without left ventricular involvement ( P =0.002), but not in those with left ventricular involvement ( P =0.08). Conclusions: Lower cardiac magnetic resonance‐derived RA reservoir strain was independently associated with end‐stage HF and MVA in arrhythmogenic right ventricular cardiomyopathy and provided incremental prognostic value beyond conventional risk markers. These findings support RA mechanics as a potential complementary component of multichamber CMR risk assessment, pending external validation.